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The same enzyme is responsible for the activation of
transforming growth factor-b-like signalling molecules
and the processing of fibrillar procollagens. This finding
implicates a metalloendoprotease in the control of cell
behavior and matrix assembly during morphogenesis.
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The assembly of tissues and organs during development
involves processes that control cell fate and differentiation,
regulate extracellular matrix production and modulate
matrix assembly. For example, during skeletal morphogen-
esis, mesenchymal cells derived from neural crest, somites
and lateral plate differentiate into chondrocytes and
osteoblasts, produce distinct sets of matrix components
and assemble the components into specific matrices.
These processes must be carefully integrated for cartilage
and bone to form, but relatively little is known about how
this integration is accomplished. In a recent publication,
Kessler et al. [1] provide evidence that a proteolytic
enzyme within the extracellular matrix may represent an
‘integrative control point’. Their data demonstrate that the
endoprotease responsible for cleaving the carboxyl (C)-
propeptides of fibrillar procollagens I, II and III is identical
to bone morphogenetic protein-1 (BMP-1).
Procollagens I, II and III are the precursors of the major
fibrillar collagens in vertebrate matrices [2]. They are
homotrimeric or heterotrimeric molecules that contain a
central triple-helical, fibril-forming domain flanked by
amino and carboxyl propeptide domains (Fig. 1). Fibrils
cannot form unless the propeptides are removed; their
cleavage by specific endoproteases is therefore a necessary
step in fibrillogenesis. In tissues such as cartilage and
bone, this processing of procollagens is of major impor-
tance for normal morphogenesis because of the large
amount of matrix and the critical role of the collagen fibril
scaffold in the structure and function of the matrix.
The procollagen C-proteinase (PCP), responsible for
removing the C-propeptide, is an N-glycosylated metallo-
protease that requires calcium for optimal activity [3]. The
activity of PCP is stimulated by another glycoprotein, the
procollagen C-proteinase enhancer (PCPE) [4]. PCP and
PCPE bind to the C-propeptide and to each other. Both
chick and mouse PCPs have been purified and shown to
cleave the two chains of procollagen I at a specific Ala–Asp
bond. Interestingly, many of the properties of PCP, such
as its molecular mass and calcium requirement, are close
to those expected for the mature form of BMP-1, a metal-
loprotease with bone-inductive activity that was first iso-
lated from osteogenetic fractions of bone together with
other bone morphogenetic proteins (BMPs) [5].
It had been known for a long time that extracts of dem-
ineralized bone could induce new bone formation, but the
molecular characteristics of the active components did not
become clear until the bone morphogenetic proteins were
cloned. The BMPs are members of the transforming
growth factor-b (TGF-b) superfamily, with the exception
of BMP-1, which is homologous to proteins such as the
product of the zygotic dorsal–ventral patterning gene
tolloid (tld) in Drosophila, the crayfish digestive endopepti-
dase astacin, and the sea urchin proteins SpAN and BP10
[6]. Each of these proteins contains several domains: an
amino-terminal region of astacin-like protease structure,
and varying numbers of EGF-like repeats and domains
involved in protein–protein interactions (CUB domains)
[7]. In Drosophila, the tolloid protease is involved in pro-
cessing the precursor of the BMP-2/4-like product of the
decapentaplegic (dpp) gene; BMP-1 may likewise activate
latent forms of BMPs or other TGF-b-like molecules.
The similarities between BMP-1 and PCP led Kessler et
al. [1] to compare recombinant BMP-1 (rBMP-1) with
purified mouse PCP in several ways. First, they checked
whether rBMP-1 has PCP activity. Many proteolytic
enzymes can mimic the activity of PCP by removing the
C-propeptide from procollagen I, but only PCP cleaves at
a specific Ala–Asp bond. With procollagen I as substrate,
Kessler et al. [1] showed not only that rBMP cleaved the
molecule into fragments of the correct size, as estimated
by polyacrylamide gel electrophoresis, but also that the
carboxyl fragment had the correct Asp residue at its
amino terminus. In addition, procollagen III present as a
contaminant in the procollagen I preparation was cleaved
at the correct Gly–Asp bond. Furthermore, the activity of
rBMP-1 with procollagen I as substrate was stimulated by
the enhancer protein PCPE, and several inhibitors had
similar effects on PCP and on BMP-1.
In further experiments, Kessler et al. [1] showed that
rBMP-1 and PCP bound to and could be eluted from
lysyl–Sepharose and C-propeptide–Sepharose columns
under the same conditions. Antibodies directed against
rBMP-1 recognized PCP in immunoblots, and although
rBMP-1 and mouse PCP migrated as two bands on gels,
after treatment with peptide–N-glycosidase F the two
proteins migrated as a single band. Finally, partial sequenc-
ing of two fragments of mouse PCP showed sequences
consistent with those of human and mouse BMP-1. Thus,
PCP and BMP-1 seem to be identical proteins.
As TGF-b-like or BMP-1/tolloid-like proteins are impli-
cated in various patterning processes in diverse organisms
from flies to mammals [6], the fact that BMP-1 is identical
to one of the two proteases that cleave procollagen mole-
cules raises the exciting possibility that it represents a
nexus for integrating cellular responses to cytokines and
the assembly of extracellular matrices. In its simplest
form, the idea would be that BMP-1, through its ability to
activate TGF-b/BMP-like molecules within complexes of
latent precursors and TGF-b binding proteins, indirectly
regulates matrix production, while at the same time it con-
trols collagen fibril assembly by removing the C-propep-
tide from procollagens (Fig. 1). This is almost certainly too
simplistic, however, as several observations indicate the
existence of more than one BMP-1-like protease. 
In Drosophila, for example, a close homologue of the tolloid
gene, tolloid-related-1 (tlr-1), shows distinct expression pat-
terns in late-stage embryos, suggesting the existence of a
homologue of BMP-1 with a tissue-specific function [8].
Also, two PCPs with slightly different properties have been
purified from chick embryo calvaria and tendons [3,9]. And
as the BMP-1 gene generates alternatively spliced tran-
scripts encoding PCP and a longer protein, mammalian
tolloid (mtld) [1], it is possible that a whole family of BMP-
1-like proteases exist in mammals. Members of such a
family could have overlapping but different activities and
specificities for various TGF-b superfamily members
and/or different types of procollagens and other non-col-
lagenous matrix molecules. The cleavage site for PCP in
fibrillar procollagens lies within a non-triple-helical domain,
and the enzyme does not distinguish between single pro-
collagen chains or folded trimeric molecules. Thus, PCP or
related proteases may cleave sites in non-collagenous
matrix molecules as well as those in fibrillar procollagens.
But should the activities of these enzymes be restricted to
collagenous proteins, there are plenty of potential sub-
strates. At the latest count there were about 35 genes in the
collagen superfamily, encoding polypeptide subunits of
about 20 different types of homotrimeric or heterotrimeric
molecule [2]. Not all of these types are proteolytically
cleaved like procollagens I, II and III to yield fibril-forming
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Figure 1
Procollagen C-proteinase (PCP = BMP-1)
serves as a processing enzyme for
procollagen and for molecules belonging to
the TGF-b superfamily. In conjunction with a
glycoprotein enhancer (PCPE), it cleaves
procollagen between the triple-helical domain
(pink) and the C-propeptide (blue) to produce
a pN-collagen product (which will be further
cleaved by an N-proteinase; not illustrated).
As PCP binds to the C-propeptide and PCPE,
the PCPE/C-propeptide complex may serve to
sequester PCP within the matrix. As a
processing enzyme for cytokines in the TGF-b
superfamily, PCP may cleave precursors while
they are complexed with binding proteins such
as the latent TGF-b binding proteins (LTBP).
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triple-helical units, but some degree of processing has been
demonstrated for many and is likely for others. Particularly
significant may be the processing of so-called minor fibrillar
procollagens, various combinations of polypeptide products
of collagen V and XI genes [2]. These molecules are
expressed in tissue-specific patterns, copolymerize with the
major collagens I and II in fibrils, and regulate the proper-
ties of the fibrils and fibrillar scaffolds. For example, muta-
tions in two of the genes in this group, Col11a1 and Col5a2,
result in increased collagen fibril diameters, dramatic
reduction in tensile strength and cohesive properties of
extracellular matrices, and alterations in cell differentiation
and/or proliferation [10,11]. Whereas procollagens I, II and
III are cleaved by both procollagen N-proteinases and C-
proteinases, the minor procollagens V/XI seem to be
processed only at the C-propeptide. Their cleavage by PCP
is therefore a potential mechanism for controlling their
incorporation into fibrils and regulating the mechanical
properties of fibrillar scaffolds.
The report by Kessler et al. [1] ties together ideas and data
from fields as diverse as those of patterning processes in
flies, sea urchins and frogs, bone induction in mammals,
and collagen fibril assembly. This is the sort of unexpected
discovery that deserves a response such as Hecate’s in
Macbeth: “O, well done! I commend your pains; And every
one shall share i’ th’ gains.” The stage is set for further
developments in this interesting story.
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